Tudpock18 said...
BillyBob, could you please provide a link to the Tewari study that you quoted. Some of the numbers you show don't seem to make any sense out of context, e.g. age of participants, Gleason scores, type of radiation treatment compared, etc. The devil is always in the details...
Thanks,
Jim
Sure, I'll try. Here's for the abstract:
www.ncbi.nlm.nih.gov/pubmed/17296374I have a copy of the full report on my computer. But I can't figure out where I got it, where the link is. The only one I can find a link to you have to pay for it. And I know I did pay not for it.
OK, here is a link. When I clicked on it, it does not take me to a web page but just downloads the PDF file directly to my computer. If that doesn't work for you, I can copy some segments from the PDF file that I have.
r.search.yahoo.com/_ylt=A86.JyIDgF9VlBwAggMnnIlQ;_ylu=X3oDMTByYnR1Zmd1BGNvbG8DZ3ExBHBvcwMyBHZ0aWQDBHNlYwNzcg--/RV=2/RE=1432350852/RO=10/RU=http%3a%2F%2Fwebdoc.nyumc.org%2Fnyumc%2Ffiles%2Furology%2Fattachments%2Ftewari_j_urol.pdf/RK=0/RS=IOdbQ8Inmg_R_pKLdtN3YvstXso-I think this could account for at least some of the surprising results:
Somebody said...
Table 1 shows the study population. Patients treated with RT were older than men treated conservatively or with RP (meanSDage68.05.8vs60.05.7and62.96.2)and they also had more comorbidities (RT, conservative manage- ment and RP Charlson scores 1.81 1.51, 1.44 1.26 and 1.23 1.21, respectively). Black patients represented 57.6% of the study group and they were less likely to undergo RP than white patients (20.0% vs 31.0%)
Somebody said...
................In diseases such as high grade prostate cancer, for which randomized studies are nonexistent or do not include all treatment groups, it is appropriate to resort to observational studies and attempt to decrease their inherent biases to help patients and clinicians assess and compare treatment risks more accurately. With this aim in mind we used propensity scoring methodology, a valid statistical approach that has been used in several such studies,3– 6 enabling us to compare all 3 treatment modalities. We noted that for a given quintile the overall risk of death in patients undergoing RP was 68% lower than in those with conservative treatment and 54% lower than in those with RT.
Our study strengths are its large database, intent to treat analysis, propensity score modeling, representation of black race, single institution setting, capture of comorbidity and adjustment for baseline confounders. Therefore, the findings are a useful addition to the existing literature.
Post Edited (BillyBob@388) : 5/22/2015 1:36:35 PM (GMT-6)